Item
Magnesium Stearate RSPO MB USP/NF (MGSTPD-NI)
We herewith on the basis of available information declare that Stearic Acid 50 Powder - RSPO MB does not contain any allergens.
Fatty Acids
Attributes
- Halal
- Ingredient declaration
- Kosher
- PHO-free
- Ready-to-Eat (RTE)
- Vegan
- Non-GMO
Locations
| Location name | Address |
|---|---|
| GENERICHEM CORP.- Nitika Pharmaceutical Specialties Pvt LTD | Block no 03 of plot no 1296 1297/08 Ward no 03 Mouza-Waddhamana Tah-Hingna Amravati Road Nagpur-2, MH 440023 IND |
| Generichem Corporation | 425 Main Road Suite 2 Towaco, NJ 07082 |
| Generichem Corporation - Nitika Pharmaceutical Specialties | Block No 3, Plot No 1296,1297,08, Ward No 3, Mauza-Waddhamna Nagpur, MH 440001 IND |
Documents
| Type | Location | File name | Effective | Expiration |
|---|---|---|---|---|
| Allergens | Generichem Corporation - Nitika Pharmaceutical Specialties | Allergens.pdf | 1/9/2021 | 1/9/2023 |
| Country of Origin | Generichem Corporation - Nitika Pharmaceutical Specialties | Country of Origin.pdf | 1/9/2021 | 1/9/2024 |
| Item Questionnaire | Generichem Corporation - Nitika Pharmaceutical Specialties | Item Questionnaire.pdf | 1/9/2021 | 1/9/2022 |
| HACCP Process Flow Diagram | Generichem Corporation | Magnesium Stearate Process Flow chart with CCP.pdf | 3/10/2022 | 3/9/2024 |
| HACCP | GENERICHEM CORP.- Nitika Pharmaceutical Specialties Pvt LTD | Magnesium Stearate Process Flow chart with CCP.pdf | 5/26/2021 | 5/25/2024 |
| HACCP Process Flow Diagram | GENERICHEM CORP.- Nitika Pharmaceutical Specialties Pvt LTD | Magnesium Stearate Process Flow chart with CCP.pdf | 5/26/2021 | 5/26/2023 |
| HARPC Food Safety Plan (Item) | GENERICHEM CORP.- Nitika Pharmaceutical Specialties Pvt LTD | Magnesium Stearate Process Flow chart with CCP.pdf | 2/8/2022 | 2/7/2025 |
| Animal Testing Statement | GENERICHEM CORP.- Nitika Pharmaceutical Specialties Pvt LTD | Magnesium Stearate RSPO MB - Animal Testing Statement.pdf | 10/20/2022 | 10/20/2024 |
| No Animal Ingredient Statement | Generichem Corporation | Magnesium Stearate RSPO MB - BSE, TSE Statement.pdf | 10/11/2022 | 10/11/2023 |
| California Prop. 65 | GENERICHEM CORP.- Nitika Pharmaceutical Specialties Pvt LTD | Magnesium Stearate RSPO MB - Calif Prop 65.pdf | 10/26/2022 | 10/25/2024 |
| Ingredient Statement | Generichem Corporation | Magnesium Stearate RSPO MB - Composition statement.pdf | 10/11/2022 | 10/11/2023 |
| Gluten | Generichem Corporation | Magnesium Stearate RSPO MB - Gluten Free Statement.pdf | 11/10/2022 | 11/10/2023 |
| GMO | GENERICHEM CORP.- Nitika Pharmaceutical Specialties Pvt LTD | Magnesium Stearate RSPO MB - GMO Statement.pdf | 10/26/2022 | 10/25/2024 |
| GMO | Generichem Corporation - Nitika Pharmaceutical Specialties | Magnesium Stearate RSPO MB - GMO Statement.pdf | 2/7/2024 | 2/6/2026 |
| GRAS/NDI/ODI Statement | GENERICHEM CORP.- Nitika Pharmaceutical Specialties Pvt LTD | Magnesium Stearate RSPO MB - GRAS Statement.pdf | 10/26/2022 | 10/26/2024 |
| GRAS/NDI/ODI Statement | Generichem Corporation - Nitika Pharmaceutical Specialties | Magnesium Stearate RSPO MB - GRAS Statement.pdf | 10/15/2022 | 10/14/2025 |
| Halal | GENERICHEM CORP.- Nitika Pharmaceutical Specialties Pvt LTD | Magnesium Stearate RSPO MB - HALAL Certificate (exp 04.25.2024).pdf | 4/23/2023 | 4/25/2024 |
| Halal | Generichem Corporation - Nitika Pharmaceutical Specialties | Magnesium Stearate RSPO MB - HALAL Certificate (exp 04.25.2025).pdf | 4/26/2024 | 4/27/2025 |
| Kosher | GENERICHEM CORP.- Nitika Pharmaceutical Specialties Pvt LTD | Magnesium Stearate RSPO MB - KOSHER Certificate (exp 02.28.2024).pdf | 2/23/2023 | 2/28/2024 |
| Kosher | Generichem Corporation | Magnesium Stearate RSPO MB - KOSHER Certificate (exp 02.28.2024).pdf | 2/23/2023 | 2/28/2024 |
| Melamine | GENERICHEM CORP.- Nitika Pharmaceutical Specialties Pvt LTD | Magnesium Stearate RSPO MB - Melamine Statement.pdf | 10/26/2022 | 10/26/2023 |
| Melamine | Generichem Corporation | Magnesium Stearate RSPO MB - Melamine Statement.pdf | 10/11/2022 | 10/11/2023 |
| Natural | Generichem Corporation | Magnesium Stearate RSPO MB - Natural-Synthetic Derivation Statement.pdf | 3/21/2022 | 3/21/2023 |
| Irradiation Status Statement | GENERICHEM CORP.- Nitika Pharmaceutical Specialties Pvt LTD | Magnesium Stearate RSPO MB - Non-Irradiated Statement.pdf | 11/2/2022 | 11/1/2024 |
| Irradiation Status Statement | Generichem Corporation - Nitika Pharmaceutical Specialties | Magnesium Stearate RSPO MB - Non-Irradiated Statement.pdf | 2/7/2024 | 2/6/2026 |
| Residual Statement | Generichem Corporation - Nitika Pharmaceutical Specialties | Magnesium Stearate RSPO MB - Residual Solvent Statement.pdf | 2/7/2024 | 2/6/2025 |
| Safety Data Sheet (SDS) | GENERICHEM CORP.- Nitika Pharmaceutical Specialties Pvt LTD | Magnesium Stearate RSPO MB - SDS.pdf | 10/26/2022 | 10/25/2024 |
| Safety Data Sheet (SDS) | Generichem Corporation - Nitika Pharmaceutical Specialties | Magnesium Stearate RSPO MB - SDS.pdf | 2/7/2024 | 2/6/2026 |
| Sewage Statement | Generichem Corporation - Nitika Pharmaceutical Specialties | Magnesium Stearate RSPO MB - Sewage sludge statement.pdf | 2/7/2024 | 2/6/2026 |
| Product Specification Sheet | GENERICHEM CORP.- Nitika Pharmaceutical Specialties Pvt LTD | Magnesium Stearate RSPO MB - Specification Sheet.pdf | 10/26/2022 | 10/25/2025 |
| CoA Sample | Generichem Corporation - Nitika Pharmaceutical Specialties | Magnesium Stearate RSPO MB - Typical CofA.pdf | 10/11/2022 | 10/10/2024 |
| Vegan/Vegetarian Statement | GENERICHEM CORP.- Nitika Pharmaceutical Specialties Pvt LTD | Magnesium Stearate RSPO MB - Vegan Statement.pdf | 10/26/2022 | 10/26/2024 |
| Vegan/Vegetarian Statement | Generichem Corporation - Nitika Pharmaceutical Specialties | Magnesium Stearate RSPO MB - Vegan Statement.pdf | 2/7/2024 | 10/22/2024 |
| CoA Sample | GENERICHEM CORP.- Nitika Pharmaceutical Specialties Pvt LTD | MGST9K2040.pdf | 5/26/2021 | 5/26/2023 |
| CoA Sample | Generichem Corporation | MGST9K2253.pdf | 3/1/2022 | 2/29/2024 |
| Animal Testing Statement | Generichem Corporation | MGSTPD RSPO MB - Animal Testing Statement.pdf | 6/27/2022 | 6/27/2024 |
| BSE - TSE | Generichem Corporation | MGSTPD RSPO MB - BSE TSE Statement.pdf | 3/1/2022 | 2/28/2025 |
| California Prop. 65 | Generichem Corporation | MGSTPD RSPO MB - California Prop 65 Statement.pdf | 3/1/2022 | 2/29/2024 |
| Ingredient Statement | Generichem Corporation - Nitika Pharmaceutical Specialties | MGSTPD RSPO MB - Composition Statement.pdf | 11/17/2021 | 11/17/2022 |
| Heavy Metal | Generichem Corporation | MGSTPD RSPO MB - Elemental Impurity Risk Assessment.pdf | 3/1/2022 | 2/29/2024 |
| EtO Statement | Generichem Corporation | MGSTPD RSPO MB - ETO Statement.pdf | 3/1/2022 | 2/29/2024 |
| EtO Statement | GENERICHEM CORP.- Nitika Pharmaceutical Specialties Pvt LTD | MGSTPD RSPO MB - ETO Statement.pdf | 2/8/2022 | 2/8/2024 |
| GMO | Generichem Corporation | MGSTPD RSPO MB - GMO Statement.pdf | 3/1/2022 | 2/29/2024 |
| GRAS/NDI/ODI Statement | Generichem Corporation | MGSTPD RSPO MB - GRAS Statement.pdf | 3/1/2022 | 2/28/2025 |
| Halal | Generichem Corporation | MGSTPD RSPO MB - HALAL Certificate exp 04252023.pdf | 4/25/2023 | |
| Kosher | Generichem Corporation - Nitika Pharmaceutical Specialties | MGSTPD RSPO MB - KOSHER Certificate exp 02282022.pdf | 2/28/2022 | |
| Organic | Generichem Corporation | MGSTPD RSPO MB - NOID (Non Organic Ingredient Declaration).pdf | 9/20/2022 | 9/20/2024 |
| Organic | Generichem Corporation - Nitika Pharmaceutical Specialties | MGSTPD RSPO MB - NOMA - Non Organic Material Affidavit.pdf | 6/29/2021 | 6/29/2023 |
| Irradiation Status Statement | Generichem Corporation | MGSTPD RSPO MB - Non-Irradiated Statement.pdf | 3/1/2022 | 2/29/2024 |
| Food Contact Packaging Certificate of Compliance | Generichem Corporation - Nitika Pharmaceutical Specialties | MGSTPD RSPO MB - Packaging Declaration.pdf | 4/7/2021 | 4/7/2023 |
| Pesticide | Generichem Corporation | MGSTPD RSPO MB - Pesticide Free Statement.pdf | 3/1/2022 | 2/29/2024 |
| Pesticide | Generichem Corporation - Nitika Pharmaceutical Specialties | MGSTPD RSPO MB - Pesticide Free Statement.pdf | 10/28/2020 | 10/28/2022 |
| Residual Statement | Generichem Corporation | MGSTPD RSPO MB - Residual Solvent Statement.pdf | 3/1/2022 | 3/1/2023 |
| Safety Data Sheet (SDS) | Generichem Corporation | MGSTPD RSPO MB - SDS.pdf | 3/1/2022 | 2/28/2025 |
| Lot Code | Generichem Corporation | MGSTPD RSPO MB - SIDI.pdf | 3/1/2022 | 2/28/2025 |
| Shelf Life | Generichem Corporation | MGSTPD RSPO MB - SIDI.pdf | 3/1/2022 | 2/28/2025 |
| Lot Code | Generichem Corporation - Nitika Pharmaceutical Specialties | MGSTPD RSPO MB - SIDI.pdf | 1/6/2021 | 1/6/2024 |
| Shelf Life | Generichem Corporation - Nitika Pharmaceutical Specialties | MGSTPD RSPO MB - SIDI.pdf | 1/6/2021 | 1/6/2023 |
| Product Specification Sheet | Generichem Corporation | MGSTPD RSPO MB - Specification Sheet.pdf | 3/1/2022 | 2/28/2025 |
| Product Specification Sheet | Generichem Corporation - Nitika Pharmaceutical Specialties | MGSTPD RSPO MB - Specification Sheet.pdf | 2/23/2022 | 2/22/2025 |
| Vegan/Vegetarian Statement | Generichem Corporation | MGSTPD RSPO MB - Vegetable Statement.pdf | 3/1/2022 | 2/29/2024 |
| WADA/NSF/NFL Statement | Generichem Corporation | MGSTPD RSPO MB - WADA Statement.pdf | 3/1/2022 | 2/29/2024 |
| Label Sample | Generichem Corporation | MGSTPD-NI.jpg | 3/1/2022 | 3/1/2023 |
| Label Sample | Generichem Corporation - Nitika Pharmaceutical Specialties | MGSTPD-NI.jpg | 2/7/2024 | 2/6/2025 |
| HARPC Food Safety Plan (Item) | Generichem Corporation | Nitika - Safety Health Environment Policy SHE.pdf | 3/10/2022 | 3/9/2025 |
| HACCP Process Flow Diagram | Generichem Corporation - Nitika Pharmaceutical Specialties | NP QA-HACCP-00 Magnesium Stearate Process Flow Chart.pdf | 4/10/2023 | 4/9/2025 |
| Nutrition | Generichem Corporation - Nitika Pharmaceutical Specialties | Nutrition.pdf | 1/9/2021 | 1/9/2024 |
| Suitability Requirements | Generichem Corporation - Nitika Pharmaceutical Specialties | Suitability Requirements.pdf | 1/9/2021 | 1/9/2024 |
